Core Laboratories Future Growth

Future criteria checks 2/6

Core Laboratories is forecast to grow earnings and revenue by 19.7% and 4.5% per annum respectively. EPS is expected to grow by 19.7% per annum. Return on equity is forecast to be 17.5% in 3 years.

Key information

19.7%

Earnings growth rate

19.7%

EPS growth rate

Energy Services earnings growth	21.3%
Revenue growth rate	4.5%
Future return on equity	17.5%
Analyst coverage	Good
Last updated	13 Aug 2024

Recent future growth updates

Recent updates

It's Unlikely That Core Laboratories Inc.'s (NYSE:CLB) CEO Will See A Huge Pay Rise This Year

May 02

Is Core Laboratories Inc. (NYSE:CLB) Trading At A 25% Discount?

Mar 26

Why We're Not Concerned About Core Laboratories Inc.'s (NYSE:CLB) Share Price

Mar 02

Core Laboratories: EPS Miss, But Beneficial Outlook About Exploration Efforts

Nov 09

Returns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning Picture

Sep 08

Core Laboratories: 'Spooked The Herd' In June, Things Might Be Looking Up

Aug 16

Core Laboratories Inc.'s (NYSE:CLB) Earnings Haven't Escaped The Attention Of Investors

Jul 05

The Returns On Capital At Core Laboratories (NYSE:CLB) Don't Inspire Confidence

May 25

Earnings and Revenue Growth Forecasts

NYSE:CLB - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	585	55	61	75	3
12/31/2025	579	56	58	72	7
12/31/2024	534	39	37	54	7
6/30/2024	514	24	30	42	N/A
3/31/2024	511	38	22	33	N/A
12/31/2023	510	37	14	25	N/A
9/30/2023	509	41	9	19	N/A
6/30/2023	510	39	15	25	N/A
3/31/2023	503	24	6	16	N/A
12/31/2022	490	19	15	25	N/A
9/30/2022	487	15	6	19	N/A
6/30/2022	479	9	11	25	N/A
3/31/2022	477	10	21	34	N/A
12/31/2021	470	20	23	37	N/A
9/30/2021	459	31	5	18	N/A
6/30/2021	446	33	15	26	N/A
3/31/2021	443	19	32	44	N/A
12/31/2020	487	-97	45	58	N/A
9/30/2020	530	-101	77	91	N/A
6/30/2020	598	-80	79	96	N/A
3/31/2020	651	-55	66	86	N/A
12/31/2019	668	94	67	90	N/A
9/30/2019	685	92	83	106	N/A
6/30/2019	694	90	82	104	N/A
3/31/2019	700	96	90	114	N/A
12/31/2018	701	80	89	112	N/A
9/30/2018	698	93	98	120	N/A
6/30/2018	678	91	103	126	N/A
3/31/2018	661	87	N/A	118	N/A
12/31/2017	648	81	N/A	124	N/A
9/30/2017	627	75	N/A	102	N/A
6/30/2017	608	71	N/A	107	N/A
3/31/2017	598	67	N/A	116	N/A
12/31/2016	590	65	N/A	132	N/A
9/30/2016	628	64	N/A	158	N/A
6/30/2016	682	81	N/A	167	N/A
3/31/2016	738	99	N/A	186	N/A
12/31/2015	798	115	N/A	219	N/A
9/30/2015	893	166	N/A	268	N/A
6/30/2015	972	199	N/A	299	N/A
3/31/2015	1,036	228	N/A	317	N/A
12/31/2014	1,085	257	N/A	303	N/A
9/30/2014	1,083	256	N/A	293	N/A
6/30/2014	1,080	251	N/A	293	N/A
3/31/2014	1,075	247	N/A	296	N/A
12/31/2013	1,074	243	N/A	298	N/A
9/30/2013	1,052	233	N/A	296	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CLB's forecast earnings growth (19.7% per year) is above the savings rate (2.5%).

Earnings vs Market: CLB's earnings (19.7% per year) are forecast to grow faster than the US market (14.8% per year).

High Growth Earnings: CLB's earnings are forecast to grow, but not significantly.

Revenue vs Market: CLB's revenue (4.5% per year) is forecast to grow slower than the US market (8.6% per year).

High Growth Revenue: CLB's revenue (4.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CLB's Return on Equity is forecast to be low in 3 years time (17.5%).

Core Laboratories Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

Consensus EPS estimates fall by 14%

Core Laboratories Inc. Provides Consolidated Earnings Guidance for the Fourth Quarter of 2023

Consensus EPS estimates increase by 24%

Recent updates

What You Can Learn From Core Laboratories Inc.'s (NYSE:CLB) P/E

Investor sentiment deteriorates as stock falls 16%

Second quarter dividend of US$0.01 announced

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Core Laboratories Inc. Approves Cash Dividend, Payable on August 26, 2024

Investor sentiment improves as stock rises 15%

We Think Core Laboratories (NYSE:CLB) Can Stay On Top Of Its Debt

Core Laboratories Inc. to Report Q2, 2024 Results on Jul 24, 2024

These Return Metrics Don't Make Core Laboratories (NYSE:CLB) Look Too Strong

It's Unlikely That Core Laboratories Inc.'s (NYSE:CLB) CEO Will See A Huge Pay Rise This Year

First quarter dividend of US$0.01 announced

Core Laboratories Inc. Approves Cash Dividend, Payable on May 28, 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Core Laboratories Inc. to Report Q1, 2024 Results on Apr 24, 2024

Is Core Laboratories Inc. (NYSE:CLB) Trading At A 25% Discount?

Core Laboratories Inc., Annual General Meeting, May 08, 2024

Consensus EPS estimates fall by 14%

Why We're Not Concerned About Core Laboratories Inc.'s (NYSE:CLB) Share Price

Fourth quarter dividend of US$0.01 announced

Full year 2023 earnings: EPS misses analyst expectations

Core Laboratories Inc. Approves Cash Dividend, Payable on March 4, 2024

Core Laboratories: EPS Miss, But Beneficial Outlook About Exploration Efforts

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Core Laboratories Inc. Provides Consolidated Earnings Guidance for the Fourth Quarter of 2023

Now 21% undervalued after recent price drop

Consensus EPS estimates increase by 24%

Now 21% undervalued after recent price drop

Core Laboratories Inc. to Report Q3, 2023 Results on Nov 01, 2023

Returns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning Picture

Core Laboratories: 'Spooked The Herd' In June, Things Might Be Looking Up

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Core Laboratories Inc.'s (NYSE:CLB) Earnings Haven't Escaped The Attention Of Investors

Core Laboratories Inc. Approves to Elect Curtis Anastasio as Class I Director

Core Laboratories Inc. to Report Q2, 2023 Results on Jul 26, 2023

Investor sentiment improves as stock rises 17%